| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at Edgewise Therapeutics, Inc. with holdings across 36 companies. Recent SEC Form 4 filings include 5 buys and 21 sells.
Estimated insider holdings value: $2051.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25, 2024 | ACET Adicet Bio, Inc. | Director, 10% Owner | Buy | 3,125,000 | $2.40 | $7,500,000.00 | +47.0% | -24.1% | -62.7% | |
| Jan 23, 2024 | EWTX Edgewise Therapeutics, Inc. | Director, 10% Owner | Buy | 454,545 | $11.00 | $4,999,995.00 | +3.3% | -2.5% | +75.5% | |
| Dec 18, 2023 | IRON Disc Medicine, Inc. | Director | Sale+OE | 1,724 | $59.24 | $102,129.76 | -100% | +12.8% | +11.1% | |
| Dec 14, 2023 | IRON Disc Medicine, Inc. | Director | Sell | 433,200 | $56.75 | $24,584,100.00 | -20.3% | +12.4% | +11.4% | |
| Dec 14, 2023 | IRON Disc Medicine, Inc. | Director | Sell | 134,200 | $58.88 | $7,902,266.00 | -2.1% | +12.4% | +11.4% | |
| Nov 22, 2023 | PMVP Pmv Pharmaceuticals, Inc. | 10% Owner | Sell | 87,786 | $2.23 | $195,762.78 | -100% | -28.3% | -27.8% | |
| Oct 3, 2023 | NPCE Neuropace Inc | 10% Owner | Sell | 8,314 | $9.07 | $75,449.12 | -0.1% | +16.3% | -17.6% | |
| Aug 29, 2023 | SPRY Ars Pharmaceuticals, Inc. | Director | Buy | 500,000 | $6.20 | $3,100,000.00 | +6.6% | -34.0% | +93.8% | |
| Aug 15, 2023 | GLTO Galecto, Inc. | 10% Owner | Sell | 822,680 | $0.75 | $617,010.00 | -26.9% | -14.6% | -19.8% | |
| Jul 31, 2023 | GLTO Galecto, Inc. | 10% Owner | Sell | 209,400 | $3.00 | $628,200.00 | -6.3% | -82.6% | -81.8% |